Letter to the Editor: Treatment of Covid-19 with Fisetin flavonoid nanoparticles
Authors
Abstract:
A novel coronavirus 2019 (Covid-19) was identified in Wuhan, China causing an outbreak of pneumonia worldwide. The first infection of the coronavirus was associated with a kind of seafood. The patient of the covid-19 pandemic was accompanied by the most common symptoms of fever, lung inflammation, dry cough, and tiredness. Researchers have found that natural flavonoid and antioxidant products such as wildly phytomedicine and anti-inflammatory drugs can play a therapeutically rolls in accelerating the recovery of the viral disease. Fisetin, a known flavonoid in fruits and vegetables, is a powerful anti-inflammatory and antioxidant. With the help of drug delivery technology, fisetin can be present in nanoparticles in a targeted manner in a short time with the minimum dose and also the least side effects to create a high degree of effectiveness in the treatment of this virus.
similar resources
Role of Oral Cavity in COVID-19 : Letter to Editor
On December 2019, a large number of pneumonia cases with unknown etiology were reported in Wuhan, China. In specimens taken from the throat with a swab, a new virus was founded, which was called COVID-19 by WHO. Due to the small number of studies, we decided to investigate the role of the oral cavity in this disease.
full textTreatment of COVID-19 patients using plasma therapy: Letter to Editor
The symptoms of COVID-19, caused by the newly known type of coronavirus, vary widely from asymptomatic, mild to severe respiratory infection leading to hospitalization or death of patients. To date, no specific drug has been reported for the treatment of patients affected by this virus. One of the approaches adopted for the treatment of this disease is the use of plasma therapy, which contains ...
full textSocial approach and effectiveness of the health system to cope with the Covid 19: Letter to the Editor
No
full textThe Impact of COVID-19 on health economics: letter to the editor
No Abstract No Abstract No Abstract
full textMy Resources
Journal title
volume 24 issue 3
pages 283- 287
publication date 2022-05
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023